These results indicate that disease-specific amplification of tau seeds that occurs in the brains of patients with tauopathies was reproduced in cultured cells, and distinct patient-derived strains exhibited a diversity of prion-like properties, including isoform specificity and seeding activity. Here, MAPT is linked to tauopathy.